An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

NCT02087943 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)

NCT00932074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT04875169 ·Status: COMPLETED ·Phase: PHASE3

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

NCT03389893 ·Status: TERMINATED ·Phase: PHASE4

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

NCT05018806 ·Status: COMPLETED ·Phase: PHASE2

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438 ·Status: COMPLETED ·Phase: PHASE1

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

NCT05995964 ·Status: RECRUITING ·Phase: PHASE2

Study of Stapokibatrt in Children Subjects With Atopic Dermatitis

NCT06956196 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

NCT06863961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients

NCT03948334 ·Status: TERMINATED ·Phase: PHASE2

Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

NCT03575871 ·Status: COMPLETED ·Phase: PHASE3

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).

NCT05935085 ·Status: TERMINATED ·Phase: PHASE2

A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis

NCT06931990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

NCT06947993 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

NCT03011892 ·Status: COMPLETED ·Phase: PHASE2

Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)

NCT00914186 ·Status: COMPLETED ·Phase: PHASE2

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

NCT03796676 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis

NCT06216392 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

NCT05375955 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

NCT02068352 ·Status: COMPLETED ·Phase: PHASE2

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

NCT02002208 ·Status: COMPLETED ·Phase: PHASE2

A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis

NCT00106496 ·Status: COMPLETED ·Phase: PHASE4

A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)

NCT02395133 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT06832618 ·Status: RECRUITING ·Phase: PHASE3